α-Synuclein inclusions in Alzheimer and Lewy body diseases

Journal of Neuropathology and Experimental Neurology

Volumn 59, Issue 5, 2000, Pages 408-417

  Mukaetova Ladinska, E B ^a,b   Hurt, J ^a,b   Jakes, R ^c   Xuereb, J ^a,b   Honer, W G ^d   Wischik, C M ^e  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Alzheimer disease; Amyloid deposits; Cortical Lewy body disease; Neurofibrillary changes; Synuclein

Indexed keywords

ALPHA SYNUCLEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; LEWY BODY; MALE; MISSENSE MUTATION; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROCESSING;

EID: 0034015353     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/59.5.408     Document Type: Article

References (50)

1. Masliah E, Terry RD, Alford M, DeTeresa R, Hansen L. Cortical and subcortical patterns of synaptophysin-like immunoreactivity in Alzheimer's disease. Am J Pathol 1991;138:235-46
2. Terry RD, Masliah E, Salmon DP, et al. Physical basis of cognitive alterations in Alzheimer disease: Synapse loss is the major correlate of cognitive impairment. Ann Neurol 1991;30:572-80
3. Honer WG, Dickson DW, Gleeson J, Davies P. Regional synaptic pathology in Alzheimer's disease. Neurobiol Aging 1992;13: 375-82
4. Cabalka LM, Hyman BT, Goodlett CR, Ritchie TC, Van Hoesen GW. Alteration in the pattern of nerve terminal protein immunoreactivity in the perforant pathway in Alzheimer's disease and in rats after entorhinal lesions. Neurobiol Aging 1992;13:283-91
5. Scheff SW, Price DA. Synapse loss in the temporal lobe in Alzheimer's disease. Ann Neurol 1993;33:190-99
6. Alford MF, Masliah E, Hansen LA, Terry RD. A simple dot-immunobinding assay for quantification of synaptophysin-like immunoreactivity in human brain. J Histochem Cytochem 1994;42: 283-87
7. Cole GM, Masliah E, Shelton ER, Chan HW, Terry RD, Saitoh T. Accumulation of amyloid precursor fragment in Alzheimer plaques. Neurobiol Aging 1991;12:85-91
8. Van Gool D, De Strooper B, Van Leuven F, Dom R. Amyloid precursor protein accumulation in Lewy body dementia and Alzheimer's disease. Dementia 1995;6:63-68
9. Masliah E, Terry R. The role of synaptic proteins in the pathogenesis of disorders of the central nervous system. Brain Pathol 1993;3: 77-85
10. Masliah E, Honer WG, Mallory M, et al. Topographical distribution of synaptic-associated proteins in the neuritic plaques of Alzheimer's disease hippocampus. Acta Neuropathol (Berl) 1994;87:135-42
11. Ueda K, Fukushima H, Masliah E, et al. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc Natl Acad Sci USA 1993;90:11282-86
12. Maroteaux L, Campanelli JT, Scheller RH. Synuclein: A neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J Neurosci 1988;8:2804-15
13. Buchman VL, Adu J, Pinon LGP, Ninkina NN, Davies AM, Persyn, a member of the synuclein family, influences neurofilament network integrity. Nature Neurosci 1998;1:101-3
14. Petersen K, Olesen OF, Mikkelsen JD. Developmental expression of α-synuclein in rat hippocampus and cerebral cortex. Neuroscience 1999;91:651-59
15. Maroteaux L, Scheller RH. The rat brain synucleins; family of proteins transiently associated with neuronal membrane. Mol Bran Res 1991;11:335-43
16. Jakes R, Spillantini MG, Goedert M. Identification of two distinct synucleins from human brain. FEBS Lett 1994;345:27-32
17. Tobe T. Nakajo S, Tanaka A, et al. Cloning and characterization of the cDNA encoding a novel brain-specific 14-kDa protein. J Neurochem 1992;59:1624-29
18. Shibayama-Imazu T, Okahashi I, Omata K, et al. Cell and tissue distribution and developmental changes of neuron specific 14 kDa protein (phosphoprotein 14). Brain Res 1993;622:17-25
19. Iwai A, Masliah E, Yoshimoto M, et al. The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron 1995;14:467-75
20. Iwai A, Yoshimoto M, Masliah E, Saitoh T. Non-Aβ component of Alzheimer's disease amyloid (NAC) is amyloidogenic. Biochemistry 1995;34:10139-45
21. Yoshimoto M, Iwai A, Kang D, Otero DAC, Xia Y, Saitoh T, NACP, the precursor protein of the non-amyloid β/A4 protein (Aβ) component of Alzheimer disease amyloid, binds Aβ and stimulates Aβ aggregation. Proc Natl Acad Sci USA 1995;92:9141-45
22. Masliah E, Iwai A, Mallory M, Ueda K, Saitoh T. Altered presynaptic protein NACP is associated with plaque formation and neurodegeneration in Alzheimer's disease. Am J Pathol 1996;148: 201-10
23. Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 1997;276:2045-47
24. Kruger R, Kuhn W, Muller T, et al. Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease. Nature Genetics 1998;18:106-8
25. Spillantini MG, Schmidt ML, Lee VM-Y, Trojanowski JQ, Jakes R, Goedert M. α-Synuclein in Lewy bodies. Nature 1997;388: 839-40
26. Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M. α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc Natl Acad Sci USA 1998;95:6469-73
27. Baba M, Nakajo S, Tu P-H, et al. Aggregation of α-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am J Pathol 1998;152:879-84
28. Irizzary MC, Growdon W, Gomez-Isla T, et al. Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and Cortical Lewy Body disease contain α-synuclein immunoreactivity. J Neuropathol Exp Neurol 1998;57:334-37
29. Arima K, Ueda K, Sunohara N, et al. NACP/α-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy. Acta Neuropathol (Berl) 1998;96:439-44
30. Wakabayashi K, Hayashi S, Kakita A, et al. Accumulation of α-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy. Acta Neuropathol (Berl): 96:445-52
31. Tu P-H, Calvin JE, Baba M, et al. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble α-synuclein. Ann Neurol 1998;44:415-22
32. Spillantini MG, Crowther RA, Jakes R, Cairns NJ, Lantos PL, Goedert M. Filamentous α-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. Neurosci Lett 1998;251:205-8
33. Paik SR. Lee J-H, Kim D-H, Chang C-S, Kim Y-S. Self-oligomerization of NACP, the precursor protein of the non-amyloid β/A4 protein (Aβ) component of Alzheimer's disease amyloid, observed in the presence of a C-terminal Aβ fragment (residues 25-35). FEBS Lett 1998;421:73-76
34. Crowther RA, Jakes R. Spillantini MG, Goedert M. Synthetic filaments assembled from C-terminally truncated β-synuclein. FEBS Lett 1998;436:309-12
35. McKhann G, Drachman D, Folstein MF, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA-work group under the auspices of department of health and human services, task force on Alzheimer's disease. Neurology 1984;34:939-44
36. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol (Berl) 1991;82:239-59
37. Mukaetova-Ladinska EB, Harrington CR, Roth M, Wischik CM. Biochemical and anatomical redistribution of tau protein in Alzheimer's disease. Am J Pathol 1993;143:565-78
38. Arai H, Lee CMY, Hill WD, Greenberg BD, Trojanowski JQ. Lewy bodies contain beta-amyloid precursor proteins of Alzheimer's disease. Brain Res 1992;585:386-90
39. Mullan M, Tsuji S, Miki T, et al. Clinical comparison of Alzheimer's disease in pedigrees with codon 717 Val->Ile mutation in the amyloid precursor protein gene. Neurobiol Aging 1993;14:417-19
40. Lantos PL. Ovenstone IMK, Johnson J, Clelland CA, Roques P, Rossor MN. Lewy bodies in the brain of two members of a family with the 717 (Val to Ile) mutation of the amyloid precursor protein gene. Neurosci Lett 1994;172:77-79
41. Lannfelt L, Bogdanovic N, Appelgren H, et al. Amyloid precursor protein mutation causes Alzheimer's disease in a Swedish family. Neurosci Lett 1994;168:254-56
42. Halliday G, Brooks W, Arthur H, Creasey H, Broe GA. Further evidence for an association between a mutation in the APP gene and Lewy body formation. Neurosci Lett 1997;227:49-52
43. van Duinen SG, Lammers G-J. Maat-Schieman LC, Roos RAC. Numerous and widespread α-synuclein-negative Lewy bodies in an asymptomatic patient. Acta Neuropathol (Berl) 1999;97:533-39
44. Okamoto K, Hirai S, Iizuka T, Yanagisawa T, Watanabe M. Reexamination of granulovacuolar degeneration. Acta Neuropathol (Berl) 1991:;82:340-45
45. Mena R, Robitaille Y, Cuello C. New pattern of intraneuronal accumulation of the microtubular binding domain of tau in granulovacuolar degeneration. J Geriatr Psychiatry Neurol 1992;5:132-41
46. Iwai A, Masliah E, Sundsmo MP, et al. The synaptic protein NACP is abnormally expressed during the progression of Alzheimer's disease. Brain Res 1996;720:230-34
47. Braak E, Braak H. Alzheimer's disease: Transiently developing dendritic changes in pyramidal cells of sector CA1 of the Ammon's horn. Acta Neuropathol (Berl) 1997;93:323-25
48. Schauwecker PE, Cheng H-W, Serquinia MP, Mori N, McNeill TH. Lesion-induced sprouting of commissural/association axons and induction of GAP-43 mRNA in hillar and CA3 pyramidal neurons in the hippocampus are diminished in aged rats. J Neuroscience 1995;15:2462-70
49. Kolb B, Cote S. Ribeiro-Da-Silva A, Cuello AC. Nerve growth factor treatment prevents dendritic atrophy and promotes recovery of function after cortical injury. Neuroscience 1997,76:1139-115
50. Zhan S-S. Kamphorst W, Van Nostrand WE, Eikelenboom P. Distribution of neuronal growth-promoting factors and cytoskeletal proteins in altered neurites in Alzheimer's disease and non-demented elderly. Acta Neuropathol (Berl) 1995;89:356-62